Laminaria japonica Suppresses the Atopic Dermatitis-Like Responses in NC/Nga Mice and Inflamed HaCaT Keratinocytes via the Downregulation of STAT1
Open Access
- 23 October 2020
- Vol. 12 (11), 3238
- https://doi.org/10.3390/nu12113238
Abstract
Atopic dermatitis (AD) is a skin allergy accompanied by acute and chronic dermal inflammation. In traditional oriental medicine, Laminaria japonica has been used to treat various diseases, including inflammatory diseases. Therefore, to determine the therapeutic potential of L. japonica against AD, we investigated the inhibitory effects of L. japonica water extract (LJWE) on the inflammatory mediators and AD-like skin lesions. We determined the cell viability of LJWE-treated HaCaT cells using the cell counting kit-8 assay and the levels of inflammatory cytokines using cytometric bead array kits. Additionally, we analyzed the modulatory effects of LJWE on the signaling pathways in tumor necrosis factor-α/interferon-γ-stimulated HaCaT cells via Western blotting. Furthermore, we determined the in vivo effect of LJWE on NC/Nga mice and found that LJWE remarkably improved the skin moisture, reduced dermatitis severity, and inhibited the overproduction of inflammatory mediators in 2,4-dinitrochlorobenzene-sensitized NC/Nga mice. We also observed that LJWE inhibits the expression of inflammatory chemokines in human keratinocytes by downregulating the p38 mitogen-activated protein kinase signaling pathway and activating the signal transducer and activator of transcription 1. In conclusion, LJWE has the therapeutic potential against AD by healing AD-like skin lesions, and suppressing inflammatory mediators and major signaling molecules.This publication has 41 references indexed in Scilit:
- Thermal stabilities of polyphenols and fatty acids in Laminaria japonica hydrolysates produced using subcritical waterKorean Journal of Chemical Engineering, 2012
- Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-κB and STAT1 activation in HaCaT cellsBiochemical and Biophysical Research Communications, 2012
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunological Reviews, 2011
- Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytesArchives of Pharmacal Research, 2010
- The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-κB in HaCaT keratinocytesMolecular Immunology, 2009
- Animal Models of Atopic DermatitisJournal of Investigative Dermatology, 2009
- Clinical correlations of recent developments in the pathogenesis of atopic dermatitisAnais Brasileiros de Dermatologia, 2008
- New insights into atopic dermatitisJCI Insight, 2004
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Chinese seaweeds in herbal medicineHydrobiologia, 1984